Apr 29, 2013 by Dave WilliamsonIs Peregrine Preparing to Soar Again?The company completes enrollment for a bavituximab breast cancer trial.
Apr 29, 2013 by Dave WilliamsonThe FDA Issues a Stunning RejectionGilead receives a complete response letter for part of an already approved drug.
Apr 28, 2013 by Dave WilliamsonDoes This Common Vegetable Hold the Migraine Cure?But consumers shouldn't start eating red hot chili peppers just yet
Apr 28, 2013 by Dave WilliamsonBreaking Down AbbVie's Big UpgradeShares soared after a bullish report from investment bank Morgan Stanley, but is it time to buy?
Apr 23, 2013 by Dave WilliamsonTough Day for This Hepatitis C UnderdogIs it too little too late for Achillion?
Apr 23, 2013 by Dave WilliamsonHow This Big Pharma Is Staging a Big ComebackCan Bristol-Myers go from also-ran to the eventual hep-C champ?
Apr 23, 2013 by Dave WilliamsonA New Cure for Painkiller ConstipationThe first oral medication for opioid related constipation receives FDA approval.
Apr 22, 2013 by Dave WilliamsonBig Pharma Frantically Plays Catch-UpCan it still make up ground with a winning hep-c drug cocktail?
Apr 22, 2013 by Dave Williamson and Max MacalusoEarly Lessons From Earnings SeasonThe early returns are a mixed bag for health care stocks this quarter.
Apr 21, 2013 by Dave Williamson and Max MacalusoObama's Budget Bludgeons Big PharmaThe health-care stocks winning and losing in the president's proposed budget.
Apr 21, 2013 by Dave Williamson and Max MacalusoThe Other Landmark Supreme Court CaseWhile public attention is focused on gay marriage, it isn't the only important subject on the Supreme Court's docket.
Apr 19, 2013 by Dave WilliamsonObamacare and Sequestration Crush UnitedHealthUnitedHealth raises multiple red flags in its first quarter results.
Apr 19, 2013 by Dave WilliamsonIs This Stock the Next Big Biotech?Shares of Vertex exploded today. Is this one you need to be in on?
Apr 19, 2013 by Dave WilliamsonNot Exactly What Investors Were Looking ForHow can a stock react so badly to a successful phase 3 trial?
Apr 19, 2013 by Dave WilliamsonMarking the Way for Alzheimer's DrugsCan Eli Lilly crack the Alzheimer's code?
Apr 17, 2013 by Dave WilliamsonThe Hidden Winner of the FDA’s Anti-Generic DecisionDavid Williamson discusses Acura's big 33% pop post-FDA decision.
Apr 16, 2013 by Dave WilliamsonThis Big Pharma's Big Bet Is Paying OffEli Lilly is betting big, and it's working.
Apr 16, 2013 by Dave Williamson1 Biotech Challenging the Hep-C GoliathDavid is taking on Goliath in the gold mine hepatitis C industry.
Apr 16, 2013 by Dave WilliamsonKey Takeaways From J&J's Big QuarterJohnson & Johnson makes a strong showing this quarter. What do you need to know from the report?
Apr 15, 2013 by Dave WilliamsonDiscovering Yet Another Drug DelayThis company is king when it comes to drug delays.
